100 results
Page 3 of 5
424B5
x2gx pnki1
24 May 23
Prospectus supplement for primary offering
11:15am
8-K
EX-99.1
04t27xd1p
23 May 23
Microbot Medical Announces $1.4 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules
4:05pm
8-K
EX-99.2
ljlae w1x67f8tu
23 May 23
Microbot Medical Announces $1.4 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules
4:05pm
424B5
3xfj5lg9
23 May 23
Prospectus supplement for primary offering
12:55pm
8-K
EX-99.1
bj2te575pu13c
22 May 23
Microbot Medical Achieved 100% Success Rate for LIBERTY in Extensive Pre-Clinical Animal Study Performed by Leading European Physicians
8:30am
8-K
EX-99.1
er8 qe03em2nvzle
18 May 23
Microbot Medical to Enhance Focus on its Core Business and Prioritize
9:30am
8-K
EX-99.1
k5s7acb hd
8 May 23
Microbot Medical Initiates Preparations for First-In-Human (FIH) Cases in Brazil for the LIBERTY® Robotic System
8:30am
8-K
EX-99.1
6nj ju6j5
5 May 23
Microbot Medical Announces Final Data From Its Recent Animal Study
9:00am
8-K
EX-99.1
9lj71
3 May 23
Regulation FD Disclosure
9:00am
8-K
EX-99.1
9a5 wti48g0fud
14 Dec 22
Regulation FD Disclosure
9:12am
8-K
EX-99.1
lhhah3vx1
8 Dec 22
Microbot Medical’s Proprietary LIBERTY® Robotic System Receives Third Patent Allowance in Israel
7:10am
8-K
EX-99.1
63m4i2
18 Nov 22
Microbot Medical’s Novel LIBERTY® Robotic System Continues to be Validated with Latest U.S. Design Patent Allowance
9:08am
8-K
EX-99.1
euwc i14xk7ri4
15 Nov 22
Microbot Medical Announces New Webinar Series to Engage Stakeholders with Experts in the Healthcare Space
9:31am
8-K
EX-99.1
9qxagc 2k
3 Nov 22
Microbot Medical Receives Additional Patent Allowance in Israel for the LIBERTY® Robotic System
7:00am
8-K
EX-99.2
t7f72qjlu1o
25 Oct 22
Microbot Medical Announces $5 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
5:00pm
8-K
EX-99.1
dnh6f0hsr pt
25 Oct 22
Microbot Medical Announces $5 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
5:00pm
424B5
k1bvmuuau 6htw9
24 Oct 22
Prospectus supplement for primary offering
4:30pm
8-K
EX-99.1
sqdsu99k
18 Oct 22
Microbot Medical Accomplishes the Next-Step in the Regulatory Process for the LIBERTY® Robotic System
8:45am
8-K
EX-99.1
m66lv2kpab7mkusg
13 Oct 22
Microbot Medical Completes GLP Animal Study for the LIBERTY® Robotic System
9:34am